November 24, 2014 3:10 AM ET

Capital Markets

Company Overview of Perseus-Soros Biopharmaceutical Fund, L.P.

Company Overview

Perseus-Soros Biopharmaceutical Fund, L.P. specializes in equity investments in private and public life science companies developing biopharmaceutical products. The fund also invests in companies that are developing technologies to address bottlenecks in the drug discovery process. It typically invests between $10 million and $50 million, contingent upon the portfolio company's stage of development.

888 Seventh Avenue

30th Floor

New York, NY 10106

United States

Founded in 1999

Phone:

212-651-6380

Fax:

212-651-6379

Key Executives for Perseus-Soros Biopharmaceutical Fund, L.P.

Founder and Senior Advisor
Age: 59
Managing Partner
Age: 50
Managing Partner and Managing Director
Age: 49
Partner
Age: 42
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
BioMed Capital Group Ltd. United States
R.M. Watson Company United States
Intercontinental Capital & Investment Fund Inc. United States
Melvin & Company, LLC United States
Agri Markets, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
September 28, 2014
Ambit Biosciences Corporation
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Perseus-Soros Biopharmaceutical Fund, L.P., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.